Literature DB >> 9530221

VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells.

J D Hood1, C J Meininger, M Ziche, H J Granger.   

Abstract

Vascular endothelial growth factor (VEGF) is an endothelium-specific secreted protein that potently stimulates vasodilation, microvascular hyperpermeability, and angiogenesis. Nitric oxide (NO) is also reported to modulate vascular tone, permeability, and capillary growth. Therefore, we hypothesized that VEGF might regulate endothelial production of NO. The production of nitrogen oxides by human umbilical vein endothelial cells (HUVECs) was measured after 1, 12, 24, and 48 h of incubation with VEGF. VEGF treatment resulted in both an acute (1 h) and chronic (> 24 h) stimulation of NO production. Furthermore, Western and Northern blotting revealed a VEGF-elicited, dose-dependent increase in the cellular content of endothelial cell nitric oxide synthase (ecNOS) message and protein that may account for the chronic upregulation of NO production elicited by VEGF. Finally, endothelial cells pretreated with VEGF for 24 h and subsequently exposed to A-23187 for 1 h produced NO at approximately twice the rate of cells that were not pretreated with VEGF. We conclude that VEGF upregulates ecNOS enzyme and elicits a biphasic stimulation of endothelial NO production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530221     DOI: 10.1152/ajpheart.1998.274.3.H1054

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  152 in total

1.  More weapons in the arsenal against ischemic retinopathy.

Authors:  E Keshet
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Angiogenesis in the corpus luteum.

Authors:  L P Reynolds; A T Grazul-Bilska; D A Redmer
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

Review 3.  Angiogenesis in the female reproductive organs: pathological implications.

Authors:  Lawrence P Reynolds; Anna T Grazul-Bilska; Dale A Redmer
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

4.  Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels.

Authors:  Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-18       Impact factor: 3.117

Review 5.  Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective.

Authors:  Kejing Chen; Roland N Pittman; Aleksander S Popel
Journal:  Antioxid Redox Signal       Date:  2008-07       Impact factor: 8.401

6.  Dynamic Changes in miR-126 Expression in the Hippocampus and Penumbra Following Experimental Transient Global and Focal Cerebral Ischemia-Reperfusion.

Authors:  Zhang Hong Xiao; Li Wang; Ping Gan; Jing He; Bing Chun Yan; Li Dong Ding
Journal:  Neurochem Res       Date:  2020-02-17       Impact factor: 3.996

Review 7.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

Review 8.  [VEGF inhibitors in vitreoretinal interventions].

Authors:  N Feltgen; A Stahl
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

9.  Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.

Authors:  Suzanne E Dahlberg; Alan B Sandler; Julie R Brahmer; Joan H Schiller; David H Johnson
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

Review 10.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.